Annexin A2 interferes with complement regulation within the glomerulus
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085872" target="_blank" >RIV/00023001:_____/25:00085872 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S0021925825025098?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0021925825025098?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jbc.2025.110657" target="_blank" >10.1016/j.jbc.2025.110657</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Annexin A2 interferes with complement regulation within the glomerulus
Popis výsledku v původním jazyce
The alternative pathway of complement is an important pathogenic driver of a variety of glomerular diseases. Factor H is a soluble complement regulatory protein, and it is known to play a critical role in protecting the kidney from alternative pathway-mediated injury. Other proteins, however, can interfere with complement regulation by Factor H, thereby predisposing the kidney to injury. Annexin A2 was previously shown to bind to Factor H and is expressed by several resident cell types in the kidney. In the current study, we show that extracellular annexin A2 binds to the region of Factor H encompassing short consensus repeats 6 to 8, impairing the ability of Factor H to regulate complement activation on the surface of glomerular endothelial cells and podocytes in vitro and in vivo. Annexin A2 does not, however, impair Factor H function on extracellular matrix or guinea pig erythrocytes. Targeted deletion of annexin A2 in mice attenuates cyclosporine-induced kidney injury in mice and deficiency of annexin A2 expression reduces complement activation on the surface of extracellular vesicles released from endothelial cells in this model. Review of publicly available kidney transcription datasets revealed that annexin A2 is expressed by several cell types in the kidney, and that expression is increased in mulas an intrinsic "positive regulator" of complement activation in the kidney, promoting the inflammatory response after various kidney insults.
Název v anglickém jazyce
Annexin A2 interferes with complement regulation within the glomerulus
Popis výsledku anglicky
The alternative pathway of complement is an important pathogenic driver of a variety of glomerular diseases. Factor H is a soluble complement regulatory protein, and it is known to play a critical role in protecting the kidney from alternative pathway-mediated injury. Other proteins, however, can interfere with complement regulation by Factor H, thereby predisposing the kidney to injury. Annexin A2 was previously shown to bind to Factor H and is expressed by several resident cell types in the kidney. In the current study, we show that extracellular annexin A2 binds to the region of Factor H encompassing short consensus repeats 6 to 8, impairing the ability of Factor H to regulate complement activation on the surface of glomerular endothelial cells and podocytes in vitro and in vivo. Annexin A2 does not, however, impair Factor H function on extracellular matrix or guinea pig erythrocytes. Targeted deletion of annexin A2 in mice attenuates cyclosporine-induced kidney injury in mice and deficiency of annexin A2 expression reduces complement activation on the surface of extracellular vesicles released from endothelial cells in this model. Review of publicly available kidney transcription datasets revealed that annexin A2 is expressed by several cell types in the kidney, and that expression is increased in mulas an intrinsic "positive regulator" of complement activation in the kidney, promoting the inflammatory response after various kidney insults.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10608 - Biochemistry and molecular biology
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of biological chemistry
ISSN
0021-9258
e-ISSN
1083-351X
Svazek periodika
301
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
15
Strana od-do
"art. no. 110657"
Kód UT WoS článku
001580252400001
EID výsledku v databázi Scopus
2-s2.0-105016458807